Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

ANAKINRA (KINERET) 100 mg in 0.67mL Pre-filled Syringe

Northern Health and Social Care Trust

This public procurement record has 3 releases in its history.

Award

10 Sep 2026 at 13:24

UK7 - Contract Details Notice
Award

13 Aug 2026 at 17:06

UK6 - Contract Award Notice
Award

13 Aug 2026 at 17:00

UK5 - Transparency Notice
Summary of the contracting process

Northern Health and Social Care Trust bought ANAKINRA (KINERET) 100 mg in 0.67 mL pre-filled syringes for use within its health and social care services. This is a pharmaceutical product supply requirement, covering the specified branded medicine rather than a general medicines distribution service. Delivery is for the Trust in Northern Ireland, with the buyer based at Antrim Area Hospital in Antrim. The requirement concerns the provision of the finished medicinal product in the stated presentation and strength. It may suit pharmaceutical manufacturers, marketing authorisation holders, specialist medicines suppliers and distributors with the necessary rights and supply arrangements for ANAKINRA (KINERET).

The procurement has been awarded and the contract is active. Northern Health and Social Care Trust used a direct award because the medicine is subject to patent protection and is commercially available from a sole marketing authorisation holder, with no reasonable alternative or substitute. The award was made to ALLOGA UK LIMITED on 13 August 2026 for £300,000 excluding VAT (£360,000 including VAT). The award period runs from 1 September 2026 to 31 August 2029. The contract was signed on 10 September 2026, with its contract period running from that date to 31 August 2029, at the same value of £300,000 excluding VAT (£360,000 including VAT). There was one completed lot.

This award demonstrates established demand from Northern Health and Social Care Trust for a specialist, branded pharmaceutical supplied in a defined strength and presentation. The selected supplier is a large UK medicines business, and the procurement rationale indicates that access to the product depended on exclusive intellectual property or marketing authorisation rights. A credible competitor for a future requirement of this type would therefore need secure legal rights to supply ANAKINRA (KINERET), or a demonstrably authorised route to source and distribute it, together with reliable pharmaceutical wholesaling, regulatory compliance, quality assurance and continuity of supply. General medicines distribution capability alone would not address the stated single-supplier and no-substitute conditions.

How relevant is this notice?

Notice Information

Notice Title

ANAKINRA (KINERET) 100 mg in 0.67mL Pre-filled Syringe

Notice Description

The contract is for the supply of ANAKINRA (KINERET) 100 mg in 0.67mL Pre-filled Syringes to Northern Health and Social Care Trust for a period of up to three years

Procurement Information

Purchase of drugs which are subject to patent protection/ Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods,services or works. The product required is only commercially available from one supplier and no competition or alternative exists for this product.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e3fc
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/085881-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£300,000 £100K-£500K
Contracts Value
£300,000 £100K-£500K

Notice Dates

Publication Date
10 Sep 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
13 Aug 20262 months ago
Contract Period
10 Sep 2026 - 31 Aug 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Northern Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
ANTRIM
Postcode
BT41 2RL
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0D Antrim and Newtownabbey
Delivery Location
Not specified
Local Authority
Antrim and Newtownabbey
Electoral Ward
Springfarm
Westminster Constituency
South Antrim

Supplier Information

Number of Suppliers
1
Supplier Name

Alloga UK

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...